Richard Nagle is a life sciences entrepreneur with over 25 years’ experience in the pharmaceutical industry across the US, Europe and Australasia. He was part of the early Innovex HQ team, at the forefront of outsourcing services, where he built and managed the development of large pharmaceutical sales forces, CRA’s and marketing. Innovex was acquired by Quintiles. He was Commercial Director of Walsh/PMSI, which was acquired by IMS Health, the leading supplier of strategic research and data to the pharmaceutical industry.
Moving into drug development, he became Commercial Director of Adelphi Group, responsible for the Strategic Product Development Consultancy, advising global pharmaceutical companies. He was CEO of Cardiac Alert which was acquired by Quintiles. He developed a new drug delivery system for Alza Corporation. The product was subsequently sold to Bayer and is now sold as Duragesic™. He co-founded Melee Venture Management which founded and developed a pain management business, an agri-biotech venture which placed extracted silica into depleted soils in commercial farms, two leading scientifically based cosmetics companies and a wound healing group, Wound Solutions.